|
NMD3 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.45049999999925E-05 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.67189999999984E-06 |
| Normal-vs-Stage2 |
5.015600E-02 |
| Normal-vs-Stage3 |
8.270500E-02 |
| Normal-vs-Stage4 |
4.893800E-01 |
| Stage1-vs-Stage2 |
3.629800E-01 |
| Stage1-vs-Stage3 |
1.453770E-01 |
| Stage1-vs-Stage4 |
2.471400E-01 |
| Stage2-vs-Stage3 |
7.373800E-01 |
| Stage2-vs-Stage4 |
6.595800E-01 |
| Stage3-vs-Stage4 |
8.268200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.200960E-04 |
| Normal-vs-AfricanAmerican |
5.418300E-04 |
| Normal-vs-Asian |
3.540200E-02 |
| Caucasian-vs-AfricanAmerican |
6.446600E-01 |
| Caucasian-vs-Asian |
8.747400E-01 |
| AfricanAmerican-vs-Asian |
9.977800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.98219999980998E-07 |
| Normal-vs-Female |
5.454200E-01 |
| Male-vs-Female |
1.234950E-04 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
4.058600E-03 |
| Normal-vs-Extreme_Weight |
2.09620000024557E-07 |
| Normal-vs-Obese |
1.211860E-02 |
| Normal-vs-Extreme_Obese |
2.150800E-01 |
| Normal_Weight-vs-Extreme_Weight |
2.431400E-01 |
| Normal_Weight-vs-Obese |
4.897200E-01 |
| Normal_Weight-vs-Extreme_Obese |
8.629800E-01 |
| Extreme_Weight-vs-Obese |
2.985900E-02 |
| Extreme_Weight-vs-Extreme_Obese |
3.717000E-01 |
| Obese-vs-Extreme_Obese |
8.249600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.565200E-01 |
| Normal-vs-Age(41-60Yrs) |
8.427700E-04 |
| Normal-vs-Age(61-80Yrs) |
2.3217999999936E-05 |
| Normal-vs-Age(81-100Yrs) |
8.409700E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.638600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.375770E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.268220E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.722600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.018800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.743200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
5.14290000031004E-07 |
| Normal-VS-Type2 PRCC |
1.434400E-02 |
| Normal-VS-KIRP CIMP |
8.043600E-01 |
| Normal-VS-Unclassified PRCC |
7.701600E-02 |
| Type1 PRCC-VS-Type2 PRCC |
5.858300E-02 |
| Type1 PRCC-VS-KIRP CIMP |
1.765600E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
1.571440E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.713420E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
9.922000E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
2.377600E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.67715999999096E-05 |
| Normal-vs-N1 |
9.527000E-01 |
| Normal-vs-N2 |
2.724000E-02 |
| N0-vs-N1 |
3.044400E-03 |
| N0-vs-N2 |
9.229600E-01 |
| N1-vs-N2 |
2.539600E-01 |
|
|
